Tag Archives: Therapeutics

At a CAGR of 17.16%, Global Gout Therapeutics Market will Grow steadily during 2016-2020: Key Vendors are AstraZeneca, Horizon Pharma etc.

ResearchMoz added Latest Research Report titled ” Global Gout Therapeutics Market 2016-2020 ” to it’s Large Report database.

About Gout Therapeutics
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

Technavios analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16%

Dermatology Diagnostic Devices and Therapeutics Market – Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

“The Report Dermatology Diagnostic Devices and Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Dermatology Diagnostic Devices and Therapeutics Market

Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology

This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of

Current And Future Prospects Of Glaucoma Therapeutics Global Market During The Forecast Period 2017 – 2024

ResearchMoz presents this most up-to-date research on “Current And Future Prospects Of Glaucoma Therapeutics Global Market During The Forecast Period 2017 – 2024”.

Glaucoma Therapeutics Market: Overview 

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication, carbonic anhydrase inhibitor and cholinergic. Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure. Using topical eye drops is …

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Is Poised To Reach USD 4.34 Billion By 2025: Radiant Insights,Inc

The global Gastroesophageal Reflux Disease (GERD) therapeutics market is expected to reach USD 4.34 billion by 2025, The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime.

View Full Report with TOC @ http://www.radiantinsights.com/research/gastroesophageal-reflux-disease-gerd-therapeutics-market

The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing …

Therapeutics Global Market For Glaucoma – Share, Volume, Growth, Trends, and Forecast 2017 – 2024

ResearchMoz presents this most up-to-date research on “Therapeutics Global Market For Glaucoma – Share, Volume, Growth, Trends, and Forecast 2017 – 2024”.

Glaucoma Therapeutics Market: Overview 

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha agonist, combined medication, carbonic anhydrase inhibitor and cholinergic. Administration of these eye drops reduces the production of the fluid inside eyes thereby reducing the intraocular pressure. Using topical eye drops is an …

Autism Pipeline Global Pharmaceutical Market Review For H1 2017

Autism Pipeline Review H1 2017 Pharmaceutical and Healthcare latest pipeline guide provides comprehensive information on the therapeutics under development for Autism (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The report also reviews key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in …

Infantile Spasms Therapeutics Market Globally Grow At A CAGR Of 10.16% During The Period 2017 – 2021

ResearchMoz presents this most up-to-date research on “Infantile Spasms Therapeutics Market Globally Grow At A CAGR Of 10.16% During The Period 2017 – 2021”.

An infantile spasm is a particular type of seizure found in an epilepsy syndrome of infancy and childhood. It is also known as a West syndrome. The onset of infantile spasm is usually found in the first year of life between four months and eight months of age. The condition constitutes 2% of childhood epilepsies and 25% of epilepsies with onset in the first year of life. There are around 2,000-4,000 new cases observed in the …

Bladder Cancer Therapeutic Pipeline Market Review,H2 2016

Bladder Cancer – Pipeline Review, H2 2016 this report provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Pharmaceutical and Healthcare latest pipeline guide Bladder Cancer ? Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Bladder Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Complete report on Bladder Cancer – Pipeline Review, H2 2016 spread across 40 pages

Non Small Cell Lung Cancer (NSCLC) Global Drugs Market Forecast To Grow $26.71 Billion In 2025 At CAGR of 15.7%

This is a professional and depth research report 2016 on Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2025 that would help to know the world’s major regional market conditions of Non-Small Cell Lung Cancer (NSCLC) – Global Drug Market in the main region. The NSCLC therapeutics market is expected to grow at a positive CAGR of 15.7%, reaching $ 26.71 Billion in the 8MM by 2025. The growth of the NSCLC market during the forecast period will be driven partly by increasing incident cases of NSCLC in the US, 5EU, Japan, and China, as …